semaglutide clinical trials near me Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Overview of the global PIONEER
Description
10.1038/s41591-024-03018-2 142 ScheenA
However, the weight loss side effect has been shown to benefit people without type 2 diabetes as well
After each entry, ask the question is your self reporting honest, every month provide a few simple questions regarding accuracy about self report and see if responses are same or varied with each patient
It can be effective, but it is not suitable for everyone
doi:10.3389/fphar.2024.1416985 110
